Wednesday, September 30

Healthcare

Emergent stock jumps as FDA clears smallpox vaccine for people at high risk of mpox

09/01/20241 Min Read

clears Emergent FDA high jumps mpox people risk smallpox stock vaccine

Previous ArticleAlnylam falls after full data for heart drug that can rival Pfizer’s

Next Article Ekso Bionics prices $6M offering